Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

CTH

Citigroup Fdg (CTH)

Citigroup Fdg
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:CTH
DateTimeSourceHeadlineSymbolCompany
15/08/201620:00GlobeNewswireCynapsus Announces Positive Opinion from Data and Safety Monitoring Board on Phase 3 Parkinson's Disease Clinical Study Allow...AMEX:CTHCitigroup Fdg
19/07/201606:10GlobeNewswireCynapsus Therapeutics Announces Positive Phase 3 Dose Titration Phase Results with APL-130277 for the Treatment of OFF Episod...AMEX:CTHCitigroup Fdg
30/06/201622:00GlobeNewswireCynapsus Therapeutics Enrolls Last Patient in Pivotal Phase 3 Efficacy Trial of APL-130277 to Treat OFF Episodes in Patients ...AMEX:CTHCitigroup Fdg
30/05/201616:00GlobeNewswireCynapsus Therapeutics Announces Data Presentations at the European Academy of Neurology Annual MeetingAMEX:CTHCitigroup Fdg
15/04/201620:00GlobeNewswireCynapsus Therapeutics Announces Data Presentations at the American Academy of Neurology Annual MeetingAMEX:CTHCitigroup Fdg
08/12/201518:00GlobeNewswireCynapsus Therapeutics Announces Positive Data Presentations at World Congress on Parkinson's Disease and Related Disorders Me...AMEX:CTHCitigroup Fdg
18/07/201406:15GlobeNewswireCynapsus Therapeutics Inc : Cynapsus Therapeutics Commences Phase 2 Clinical Trials in the United StatesAMEX:CTHCitigroup Fdg
08/07/201415:00GlobeNewswireCynapsus Therapeutics Inc. : Cynapsus Therapeutics Awarded Second Grant from The Michael J. Fox Foundation for Parkinson's Re...AMEX:CTHCitigroup Fdg
14/05/201420:00GlobeNewswireCynapsus Therapeutics Inc. : Cynapsus Announces No Buccal Mucosal Irritation in FDA Registration Study of APL-130277 for Park...AMEX:CTHCitigroup Fdg
24/04/201420:00GlobeNewswireCynapsus Therapeutics Inc. : Cynapsus Announces Positive Results of CTH-104 Clinical Study of APL-130277 for Parkinson's Dise...AMEX:CTHCitigroup Fdg
28/03/201421:00GlobeNewswireCynapsus Therapeutics Inc. : Cynapsus Announces Interim Summary Results of Human Healthy Volunteer Single 25mg Study for APL-...AMEX:CTHCitigroup Fdg
13/01/201422:00GlobeNewswireCynapsus Therapeutics Inc. : Cynapsus Announces Completion of Human Healthy Volunteer Crossover Study Results for APL-130277AMEX:CTHCitigroup Fdg
15/05/201315:00GlobeNewswireCynapsus Therapeutics Inc. : Cynapsus Therapeutics Publishes White Paper on Apomorphine for 'Off' Periods in Parkinson's Dise...AMEX:CTHCitigroup Fdg
25/03/200603:00PR Newswire (US)American Stock Exchange Lists Citigroup Funding Inc.'s 7.5% Sequins Linked to UnitedHealth Group Inc.AMEX:CTH
 Showing the most relevant articles for your search:AMEX:CTH